Case Study: Seamless First-in-Human Oncology Trial Across the Globe
Discover how a Japan-based biotech successfully navigated its first-in-human oncology trial by partnering with CMIC. Learn how our end-to-end CRO solutions—from protocol design and regulatory strategy to PK/PD testing and multi-regional execution—helped accelerate development in both Japan and the U.S. See how CMIC’s integrated approach delivers speed, quality, and confidence for emerging and established biopharma alike.
Learn more about our CRO solutions from CMIC Group:
Published September 2025